Biotech firm creates weight loss pill that mimics the effects of gastric bypass surgery
SYNT-101 offers a novel approach to weight loss by temporarily altering nutrient absorption in the small intestine. Unlike GLP-1 drugs, which are administered via injection and often come with side effects such as nausea and vomiting, SYNT-101 is a once-daily pill that mimics the metabolic effects of gastric bypass surgery.Read Entire Article
SYNT-101 offers a novel approach to weight loss by temporarily altering nutrient absorption in the small intestine. Unlike GLP-1 drugs, which are administered via injection and often come with side effects such as nausea and vomiting, SYNT-101 is a once-daily pill that mimics the metabolic effects of gastric bypass surgery.
Read Entire Article
